Reported Nov 30, 2016 · Terminated

Diltiazem HCl Extended-release Capsules, USP 120 mg, 100-count bottle (NDC 0378-5220-01), 500-count bottle (NDC…

Mylan Pharmaceuticals Inc.

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Mylan Pharmaceuticals Inc. · 781 Chestnut Ridge Rd · Morgantown, WV · 26505-2730

Is this the product you have?

    • Diltiazem HCl Extended-release Capsules
    • USP 120 mg
    • 100-count bottle (NDC 0378-5220-01)
    • 500-count bottle (NDC 0378-5220-05)
    • Rx Only
  • Manufactured byMylan Pharmaceuticals Inc., Morgantown, WV, 26505 USA
Lot codes and dates
    • 0378-5220-01 Lot# 3065133
    • Exp. 03/17 0378-5220-01 Lot# 3066564
    • Exp. 05/17 0378-5220-05 Lot# 3066564
    • Exp. 05/17 0378-5220-01 Lot# 3069645
    • Exp. 08/17 0378-5220-05 Lot# 3069645
    • Exp. 08/17
Amount recalled
51,983 extended release capsules

Where it was sold

  • Nationwide

Why it was recalled

Failed Impurities/Degradation Specifications: OOS results for known compound.

This product is unlikely to cause harm, but it breaks a safety or labelling rule.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Mylan Pharmaceuticals Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Aug 1, 2017 · Data as of Sep 19, 7:18 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.